An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo

Tomoshige, K; Guo, MZ; Tsuchiya, T; Fukazawa, T; Fink-Baldauf, IM; Stuart, WD; Naomoto, Y; Nagayasu, T; Maeda, Y

Maeda, Y (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Neonatol Perinatal & Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA.; Maeda, Y (reprint author), Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA.

ONCOGENE, 2018; 37 (28): 3894

Abstract

EGFR ligands (e.g., EGF and TGFA) have been shown to be clinically associated with poor survival in lung cancer. Since TGFA itself initiates autochtho......

Full Text Link